adg126,tpst-1120,bevacizumab,tocilizumab,atezolizumab,ro7247669,tiragolumab
adagene,tempest,jw pharma,arcus biosciences,roche
['morpheus-liver', '$rcus', '$rhhby']
morpheus-liver pfs, orr &amp; safety $rhhby $rcus #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.